Kenneth W. Olander
About
In The Last Decade
Kenneth W. Olander
19 papers receiving 426 citations
Peers
Comparison fields: 5 of 49
- Ophthalmology 401
- Radiology, Nuclear Medicine and Imaging 251
- Pathology and Forensic Medicine 77
- Public Health, Environmental and Occupational Health 55
- Molecular Biology 43
Countries citing papers authored by Kenneth W. Olander
This map shows the geographic impact of Kenneth W. Olander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenneth W. Olander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenneth W. Olander more than expected).
Fields of papers citing papers by Kenneth W. Olander
This network shows the impact of papers produced by Kenneth W. Olander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenneth W. Olander. The network helps show where Kenneth W. Olander may publish in the future.
Co-authorship network of co-authors of Kenneth W. Olander
This figure shows the co-authorship network connecting the top 25 collaborators of Kenneth W. Olander. A scholar is included among the top collaborators of Kenneth W. Olander based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenneth W. Olander. Kenneth W. Olander is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 13 | |
| 2 | A randomized Phase 2 trial assessing the safety and efficacy of omidenepag isopropyl 0.002% once and twice daily in subjects with primary open-angle glaucoma or ocular hypertension (Spectrum 6) | 1 |
| 3 | Patient-reported Outcomes of Bimatoprost Ocular Ring in an Open-label Extension Study in Patients with Open-angle Glaucoma or Ocular Hypertension | 1 |
| 4 | 1 | |
| 5 | 0 | |
| 6 | 41 | |
| 7 | 41 | |
| 8 | 1 | |
| 9 | 16 | |
| 10 | 65 | |
| 11 | 10 | |
| 12 | 15 | |
| 13 | Effectiveness of nonpenetrating trabeculectomy in aphakic patients with glaucoma. | 65 |
| 14 | Trabeculectomy vs. nonpenetrating trabeculectomy: a retrospective study of two procedures in phakic patients with glaucoma. | 107 |
| 15 | 24 | |
| 16 | An analytical electron microscopic study of a corneal tattoo. | 16 |
| 17 | 10 | |
| 18 | Short exposure times in argon laser iridotomy. | 11 |
| 19 | Management of pterygia: should thiotepa be used? | 7 |
| 20 | 16 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.